Emerging Standards of Care: Implications of New K/DOQI Guidelines

ASN 2002 Satellite Symposium, Philadelphia PA, November, 2002
Access to this program is free but HDCN free zone registration is required.
Opening Remarks
Steven Fishbane, M.D.
Meeting Challenges of the New K/DOQI Guidelines
Garabed Eknoyan, M.D.
Cardiovascular Complications in CKD
Mark Sarnak, M.D.
Safety in Iron Management: Applying K/DOQI Guidelines
Steven Fishbane, M.D.

After participating in this activity, participants should be able to:

Incorporate key recommendations from the K/DOQI guidelines into nephrology practice
Assess the risks of cardiovascular disease in chronic kidney disease patients
Evaluate safety issues surrounding the management of iron deficiency anemia

Garabed Eknoyan, M.D.
Professor of Medicine
Section of Nephrology
Baylor College of Medicine
Houston, TX
Mark Sarnak, M.D.
Attending Physician
Division of Nephrology
New England Medical Center
Boston, MA

Steven Fishbane, M.D.
Associate Chairman
Department of Medicine
Winthrop-University Hospital
Mineola, NY

ACCREDITATION / DESIGNATION STATEMENT(S) :

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Medical Education Resources, Inc. Medical Education Resources, Inc. is accredited by the ACCME to sponsor continuing medical education for physicians and takes responsibility for the content, quality, and scientific integrity of this CME activity.

Medical Education Resources, Inc. designates this educational activity for a maximum of 1.5 hours in Category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.



INSTRUCTIONS FOR CME CREDIT :

To earn CME credit for viewing the lectures, please print and complete the CME Posttest questions and return with the completed Evaluation Form to Medical Education Resources, Inc. via fax at (303) 798-5731 or mail at 1500 West Canal Court, Suite 500, Littleton, Colorado 80120-5617.

CE for this program has expired.

TARGET AUDIENCE :
This program is designed for clinicians who are involved in the care of chronic renal insufficiency

FACULTY DISCLOSURE STATEMENTS :
All faculty participating in continuing medical education programs are expected to disclose to the program audience any real or apparent conflict of interest related to the subject under discussion. The faculty disclosure information is as follows:
Garabed Eknoyan, M.D., has received grants/research support from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and is a consultant for Amgen and Sigma Tau.
Mark Sarnak, M.D., has received grants/research support from Amgen.
Steven Fishbane, M.D., has received grants/research support from and is a consultant and speakers' bureay participant for Watson Pharma, Inc.

DISCLOSURE OF UNLABELED USE ASN/HDCN (if applicable):
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by FDA. Medical Education Resources, ASN, HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
All of the agents overviewed in this virtual symposium will be discussed in the context of uses for which they have not been approved by the FDA.

This educational activity is supported by an educational grant from Watson Pharmaceuticals Inc.
This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.
Although not an official part of ASN's 2002 Renal Week Program, this meeting has been reviewed
and its presentation permitted by the Society.